EN PL

EMA: Concept paper on the revision of the guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues

22.02.2011
The European Medicines Agency has published concept paper on the revision of the guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: quality issues describing the requirements to establish comparability on quality for a biological medicinal product to another one already marketed.